Anna Conway
Impact in
- Hepatology top 5%
- Hepatitis C virus research
-
- HIV, Drug Use, Sexual Risk
- Hepatitis B Virus Studies
- Substance Abuse Treatment and Outcomes
Papers in
- Hepatology 14
- Hepatitis C virus research 14
-
- HIV/AIDS Research and Interventions 7
- Co-authors
- Gregory J. Dore (10 shared papers)Jason Grebely (16 shared papers)Louisa J Degenhardt (6 shared papers)Matthew Hickman (2 shared papers)Braulio Mark Valencia Arroyo (2 shared papers)Peter T. Vickerman (2 shared papers)Clare E. French (2 shared papers)Justin Presseau (2 shared papers)
In The Last Decade
Anna Conway
28 papers receiving 366 citations
Peers
Comparison fields: 5 of 27
- Hepatology 248
- Epidemiology 64
- Infectious Diseases 24
- Public Health, Environmental and Occupational Health 40
- Applied Microbiology and Biotechnology 2
Countries citing papers authored by Anna Conway
This map shows the geographic impact of Anna Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Conway more than expected).
Fields of papers citing papers by Anna Conway
This network shows the impact of papers produced by Anna Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Conway. The network helps show where Anna Conway may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Conway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 106 | |
| 2 | 2022 | 41 | |
| 3 | 2023 | 36 | |
| 4 | 2022 | 31 | |
| 5 | 2023 | 20 | |
| 6 | 2022 | 14 | |
| 7 | 2021 | 13 | |
| 8 | 2022 | 13 | |
| 9 | 2020 | 12 | |
| 10 | 2023 | 10 | |
| 11 | 2018 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2023 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2022 | 6 | |
| 16 | 2024 | 6 | |
| 17 | 2019 | 5 | |
| 18 | 2021 | 5 | |
| 19 | 2023 | 4 | |
| 20 | 2023 | 3 |
About Anna Conway
Anna Conway is a scholar working on Hepatology, Infectious Diseases, Public Health, Environmental and Occupational Health, Epidemiology and General Health Professions, having authored 31 papers that have together received 370 indexed citations. Recurring topics across this work include Hepatitis C virus research (14 papers), HIV/AIDS Research and Interventions (7 papers), Opioid Use Disorder Treatment (6 papers), HIV, Drug Use, Sexual Risk (4 papers), Substance Abuse Treatment and Outcomes (2 papers), Ethics in Clinical Research (1 paper), Health Policy Implementation Science (1 paper) and Healthcare Systems and Challenges (1 paper). The work is most often cited by research in Hepatology (248 citations), Epidemiology (64 citations), Infectious Diseases (24 citations), Public Health, Environmental and Occupational Health (40 citations) and Applied Microbiology and Biotechnology (2 citations). Anna Conway has collaborated with scholars based in Australia, Spain and Canada. Frequent co-authors include Gregory J. Dore, Jason Grebely, Louisa J Degenhardt, Matthew Hickman, Braulio Mark Valencia Arroyo, Peter T. Vickerman, Clare E. French, Justin Presseau, Guillaume Fontaine and Behzad Hajarizadeh. Their work appears in journals such as International Journal of Drug Policy, Viruses, BMC Infectious Diseases, Drug and Alcohol Review and Social Science & Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.